Welcome to our dedicated page for MODEL N news (Ticker: MODN), a resource for investors and traders seeking the latest updates and insights on MODEL N stock.
Model N, Inc. (NYSE: MODN) is a leader in cloud-based revenue management solutions that transform complex business processes into streamlined operations. The company’s mission is to drive essential business processes such as configure, price, and quote (CPQ), contract and rebate management, business intelligence, and regulatory compliance. This transformation is achieved by turning the revenue lifecycle from a series of disconnected operations into a cohesive, end-to-end strategic process.
Model N caters to life sciences, technology, and manufacturing industries, providing solutions that meet the complex needs of some of the world's leading brands, including Johnson & Johnson, AstraZeneca, Boston Scientific, Novartis, Microchip Technology, and ON Semiconductor. Its offerings are utilized in over 100 countries, ensuring robust global reach and impact.
The company's flagship products include the Revenue Cloud for Life Sciences and the Revenue Cloud for High Tech. These platforms are designed to enhance revenue and operational efficiency while complying with stringent regulatory requirements. They enable the creation and execution of contracts, modernize sales processes, and strategically manage the revenue lifecycle.
Model N has recently launched Price Management, a new solution aimed at semiconductor, electronic component, and high-tech manufacturers to manage price execution across various sales channels globally. This solution integrates with Model N's Deal Management to provide a comprehensive pricing update system, ensuring real-time data alignment with market realities and regulatory compliance.
Additionally, the company's 2024 State of Revenue Report highlights the priorities and challenges faced by executives in pharmaceutical, medical technology, and high-tech manufacturing sectors. Key findings include the emphasis on advanced analytics and AI to improve process efficiency and cost-saving measures, while addressing issues like supply chain disruptions and regulatory changes.
Model N is currently undergoing a significant transition, with a pending acquisition by Vista Equity Partners, announced in April 2024. Despite this, the company remains focused on its core mission, providing innovative solutions to drive revenue optimization and compliance for its esteemed clientele.
For more information, visit www.modeln.com.
Model N, Inc. (MODN) announced fiscal year 2022 results showing a 13% revenue growth year-over-year, totaling $219.2 million. Q4 revenues were $58.2 million, with a gross profit of $32.6 million and a gross margin of 56%. The company reported a GAAP net loss of $28.6 million for the year, though non-GAAP net income rose 34% to $26.6 million. SaaS ARR grew 31% to $109.4 million. For Q1 and full FY 2023, Model N expects total revenues between $57.0 - $58.0 million and $241.0 - $244.0 million, respectively.
Model N, Inc. (MODN) will announce its fourth quarter and fiscal year 2022 financial results on November 8, 2022, after market close. A conference call to discuss these results and the company's outlook will be held at 2:00 p.m. PT (5:00 p.m. ET) on the same day. The call can be accessed via phone or through a live webcast on Model N’s investor relations page. The company provides cloud revenue management solutions, helping life sciences and high-tech industries minimize revenue leakage and enhance operational efficiencies.
Model N, Inc. (NYSE: MODN) reported a 10% year-over-year increase in total revenues for Q3 FY2022, amounting to $56.2 million.
Adjusted EBITDA rose 36% year-over-year to $10 million, with a margin of 18%.
The company surpassed $100 million in SaaS ARR, marking a 24% year-over-year growth. GAAP net loss decreased to $6.2 million, with non-GAAP net income up 48% to $8.5 million.
Model N expects Q4 revenues between $56.0 - $56.5 million and has provided guidance for the full fiscal year 2022.
Model N (NYSE: MODN) launched Transparency Talks, an educational series in collaboration with Pfizer and Global Pricing Innovations (GPI), aimed at helping pharmaceutical companies navigate drug pricing transparency regulations. This initiative is complemented by the introduction of the State Price Transparency Management (SPTM) solution, the first-ever SaaS tool designed for compliance with state pricing mandates. The series will cover key topics including state-level pricing insights and automation for treatment data, scheduled for August 16, August 30, and September 13.
Model N plans to announce its third quarter financial results for fiscal 2022 after market close on August 9, 2022. A conference call to discuss these results and business outlook is scheduled for 2:00 p.m. PT. Investors can access the call by dialing 877-407-4018 (U.S.) or +1-201-689-8471 (international). The call will also be available via live webcast on Model N's investor relations page. Model N specializes in revenue optimization and compliance for the pharmaceutical and high-tech sectors, serving clients in over 120 countries.
Blue Ridge has appointed three key executives: Prashant Bhatia as Chief Marketing Officer, Brian Murphy as Chief Sales Officer, and Sam Sharff as Chief Financial Officer. These appointments aim to accelerate the company's growth and innovation in supply chain management. Bhatia and Murphy bring a combined 50 years of experience in enterprise technology, while Sharff aims to strengthen financial operations. The company is focused on addressing global supply chain disruptions and enhancing its offerings through AI-driven solutions.
Model N, a pioneer in revenue optimization and compliance, announced that CEO Jason Blessing will speak at the Jefferies 2022 Software Conference on June 2, 2022, at 9:30 a.m. PT (12:30 p.m. ET). The presentation will be available live and on replay via the Model N investor relations page. Model N’s platform supports digital transformation in industries like pharmaceutical and tech, providing insights that enhance pricing and contract strategies.
Model N, Inc. (NYSE: MODN) has launched its Spring 2022 product release for the Model N Revenue Cloud, introducing a new Payment Management solution aimed at high-tech companies and enhancements for pharmaceutical and medtech sectors. The update focuses on streamlining payment processes, improving compliance automation, and expanding global pricing capabilities. Notable features include integration of point-of-sale files, enhanced rebate calculations, and improved usability for mobile applications. Model N aims to optimize revenue while ensuring compliance across various industries.
Model N, Inc. (MODN), a leader in revenue optimization and compliance, will have CEO Jason Blessing presenting at the JP Morgan 50th Annual Global Technology, Media & Communications Conference on May 25, 2022, at 5:40 a.m. PT (8:40 a.m. ET). A webcast of the presentation will be available on the Model N investor relations page. Model N specializes in automation solutions for pricing, incentives, and contract decisions, servicing notable companies across 120 countries, including Johnson & Johnson and AstraZeneca.
Model N, Inc. (NYSE: MODN) reported a strong performance for Q2 FY2022, with total revenue up 11% year-over-year at $53.3 million and adjusted EBITDA soaring 105% to $6.6 million. Subscription revenues grew 6% to $38.2 million, while gross profit increased 18% to $29.2 million, resulting in a gross margin of 55%. The company forecasts continued growth, projecting Q3 revenues between $54.5 million and $55.0 million. Model N focuses on enhancing its cloud service offerings, aiming for a successful transition in its customer base.
FAQ
What is the current stock price of MODEL N (MODN)?
What is the market cap of MODEL N (MODN)?
What does Model N, Inc. specialize in?
What are the main products offered by Model N?
Which industries does Model N serve?
What is the latest product launched by Model N?
What is Model N’s 2024 State of Revenue Report about?
Where does Model N generate most of its revenue?
Who are some of Model N’s notable clients?
What significant corporate event is Model N currently undergoing?
How does Model N address regulatory compliance for pharmaceuticals?
How can I learn more about Model N’s products and services?
